letter fattyacid oxidation cystic fibrosis nature metabolic defect cystic fibrosis cf unknown therefore undertook study fattyacid oxidation betaoxidation patient cf significant difference result obtained control either affected individual heterozygous carrier value affected individual lay within normal range unless special reason defect expressed leukocyte result indicate metabolic pathway involved fattyacid oxidation betaoxidation intact cf therefore seems unlikely reported deficiency certain essential fatty acid cf result defect fattyacid metabolism